CN Patent
CN110177792B — 制备替莫唑胺和中间体的方法
Assigned to Cristalia Produtos Quimicos e Farmaceuticos Ltda · Expires 2022-03-04 · 4y expired
What this patent protects
本发明涉及一种通过使用N‑甲基氨基甲酰基咪唑制备高产率和高纯度替莫唑胺和氨基甲酰基‑AICA中间体的有效和工业有利的方法。
USPTO Abstract
本发明涉及一种通过使用N‑甲基氨基甲酰基咪唑制备高产率和高纯度替莫唑胺和氨基甲酰基‑AICA中间体的有效和工业有利的方法。
Drugs covered by this patent
- Nubeqa (darolutamide) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.